Elagolix
Elagolix (ABT-620) is an oral gonadotropin-releasing hormone antagonist being studied for the treatment of endometriosis, uterine fibroids and PCOS.
Type of Molecule
Small MoleculeTarget
GnRHProduct Type
New Indication| Potential Indication | Region | Phase (1, 2, 3, Submitted) |
|---|---|---|
| Endometriosis | US |
Approved
|
| Uterine Fibroids | n/a |
Approved
|
| PCOS | n/a |
Phase 2
|